| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.007 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |